Report on platinum drug symposium.
Mueller
Michael D
MD
D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001897:Boronic Acids; D000069286:Bortezomib; D002945:Cisplatin; D004249:DNA Damage; D004260:DNA Repair; D004268:DNA-Binding Proteins; D004720:Endonucleases; D006801:Humans; D026901:Membrane Transport Proteins; D009369:Neoplasms / Q000188:drug therapy*; D017671:Platinum Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011719:Pyrazines
D000970:Antineoplastic Agents; D001897:Boronic Acids; D004268:DNA-Binding Proteins; D026901:Membrane Transport Proteins; D017671:Platinum Compounds; D011719:Pyrazines; D000069286:Bortezomib; C071447:ERCC1 protein, human; D004720:Endonucleases; D002945:Cisplatin